Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8503 |
High Similarity |
NPD5515 |
Phase 2 |
0.837 |
Intermediate Similarity |
NPD4515 |
Suspended |
0.809 |
Intermediate Similarity |
NPD7225 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD3802 |
Phase 3 |
0.7594 |
Intermediate Similarity |
NPD5603 |
Clinical (unspecified phase) |
0.7488 |
Intermediate Similarity |
NPD7559 |
Phase 2 |
0.7474 |
Intermediate Similarity |
NPD6608 |
Clinical (unspecified phase) |
0.7473 |
Intermediate Similarity |
NPD5183 |
Approved |
0.7473 |
Intermediate Similarity |
NPD5186 |
Approved |
0.7436 |
Intermediate Similarity |
NPD5896 |
Clinical (unspecified phase) |
0.7411 |
Intermediate Similarity |
NPD3631 |
Phase 3 |
0.7394 |
Intermediate Similarity |
NPD5078 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD4154 |
Approved |
0.7358 |
Intermediate Similarity |
NPD5923 |
Phase 1 |
0.7343 |
Intermediate Similarity |
NPD6567 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD6021 |
Clinical (unspecified phase) |
0.7264 |
Intermediate Similarity |
NPD5071 |
Phase 2 |
0.7258 |
Intermediate Similarity |
NPD6533 |
Clinical (unspecified phase) |
0.7243 |
Intermediate Similarity |
NPD8311 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD4997 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD7660 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD6654 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD5966 |
Clinical (unspecified phase) |
0.7157 |
Intermediate Similarity |
NPD3416 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD1920 |
Approved |
0.7151 |
Intermediate Similarity |
NPD1919 |
Approved |
0.715 |
Intermediate Similarity |
NPD6046 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6874 |
Approved |
0.7123 |
Intermediate Similarity |
NPD5025 |
Approved |
0.7122 |
Intermediate Similarity |
NPD6511 |
Phase 1 |
0.7122 |
Intermediate Similarity |
NPD6510 |
Phase 1 |
0.7097 |
Intermediate Similarity |
NPD6737 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD6738 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD3442 |
Approved |
0.7091 |
Intermediate Similarity |
NPD3441 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7071 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD7255 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD6478 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD3591 |
Approved |
0.7 |
Intermediate Similarity |
NPD3592 |
Approved |
0.6995 |
Remote Similarity |
NPD7449 |
Clinical (unspecified phase) |
0.6991 |
Remote Similarity |
NPD6242 |
Discontinued |
0.6986 |
Remote Similarity |
NPD5143 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD4539 |
Phase 1 |
0.6968 |
Remote Similarity |
NPD6199 |
Discontinued |
0.6967 |
Remote Similarity |
NPD5860 |
Discontinued |
0.6963 |
Remote Similarity |
NPD2821 |
Approved |
0.6963 |
Remote Similarity |
NPD6379 |
Discontinued |
0.6959 |
Remote Similarity |
NPD4020 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD4558 |
Phase 2 |
0.694 |
Remote Similarity |
NPD4939 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD5600 |
Discontinued |
0.6915 |
Remote Similarity |
NPD5294 |
Clinical (unspecified phase) |
0.6907 |
Remote Similarity |
NPD6720 |
Clinical (unspecified phase) |
0.6891 |
Remote Similarity |
NPD5680 |
Clinical (unspecified phase) |
0.6888 |
Remote Similarity |
NPD5900 |
Clinical (unspecified phase) |
0.6884 |
Remote Similarity |
NPD8149 |
Discontinued |
0.6883 |
Remote Similarity |
NPD6172 |
Clinical (unspecified phase) |
0.6881 |
Remote Similarity |
NPD5871 |
Discontinued |
0.6881 |
Remote Similarity |
NPD5042 |
Phase 1 |
0.6878 |
Remote Similarity |
NPD5967 |
Approved |
0.6875 |
Remote Similarity |
NPD3983 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD3106 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6457 |
Approved |
0.6875 |
Remote Similarity |
NPD3984 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD4491 |
Clinical (unspecified phase) |
0.6853 |
Remote Similarity |
NPD6293 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD4987 |
Clinical (unspecified phase) |
0.6837 |
Remote Similarity |
NPD5293 |
Phase 2 |
0.6837 |
Remote Similarity |
NPD3793 |
Phase 3 |
0.6837 |
Remote Similarity |
NPD5521 |
Clinical (unspecified phase) |
0.6834 |
Remote Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.6831 |
Remote Similarity |
NPD1305 |
Clinical (unspecified phase) |
0.6827 |
Remote Similarity |
NPD6238 |
Discontinued |
0.6825 |
Remote Similarity |
NPD2842 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD7032 |
Approved |
0.6818 |
Remote Similarity |
NPD2950 |
Approved |
0.6818 |
Remote Similarity |
NPD2949 |
Approved |
0.6814 |
Remote Similarity |
NPD5469 |
Phase 3 |
0.6809 |
Remote Similarity |
NPD6855 |
Clinical (unspecified phase) |
0.6806 |
Remote Similarity |
NPD5562 |
Approved |
0.6806 |
Remote Similarity |
NPD5561 |
Approved |
0.6798 |
Remote Similarity |
NPD7560 |
Approved |
0.6796 |
Remote Similarity |
NPD4423 |
Clinical (unspecified phase) |
0.6794 |
Remote Similarity |
NPD6795 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD4082 |
Approved |
0.6787 |
Remote Similarity |
NPD7545 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD7588 |
Discontinued |
0.6777 |
Remote Similarity |
NPD7174 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD6017 |
Discontinued |
0.6774 |
Remote Similarity |
NPD3949 |
Clinical (unspecified phase) |
0.6762 |
Remote Similarity |
NPD5513 |
Phase 2 |
0.6759 |
Remote Similarity |
NPD3257 |
Approved |
0.6757 |
Remote Similarity |
NPD4942 |
Approved |
0.6757 |
Remote Similarity |
NPD7186 |
Phase 3 |
0.6753 |
Remote Similarity |
NPD7206 |
Clinical (unspecified phase) |
0.6749 |
Remote Similarity |
NPD6136 |
Phase 2 |
0.6746 |
Remote Similarity |
NPD7566 |
Clinical (unspecified phase) |
0.6746 |
Remote Similarity |
NPD6321 |
Discontinued |
0.6733 |
Remote Similarity |
NPD4084 |
Clinical (unspecified phase) |
0.6731 |
Remote Similarity |
NPD5882 |
Clinical (unspecified phase) |
0.6731 |
Remote Similarity |
NPD4118 |
Clinical (unspecified phase) |
0.6731 |
Remote Similarity |
NPD1880 |
Phase 3 |
0.6716 |
Remote Similarity |
NPD6557 |
Phase 2 |
0.6715 |
Remote Similarity |
NPD5591 |
Approved |
0.6714 |
Remote Similarity |
NPD956 |
Clinical (unspecified phase) |
0.6713 |
Remote Similarity |
NPD4356 |
Discontinued |
0.6712 |
Remote Similarity |
NPD3258 |
Approved |
0.6711 |
Remote Similarity |
NPD8157 |
Clinical (unspecified phase) |
0.67 |
Remote Similarity |
NPD5620 |
Clinical (unspecified phase) |
0.67 |
Remote Similarity |
NPD7291 |
Discontinued |
0.67 |
Remote Similarity |
NPD7855 |
Clinical (unspecified phase) |
0.67 |
Remote Similarity |
NPD2792 |
Approved |
0.6698 |
Remote Similarity |
NPD4493 |
Discontinued |
0.6698 |
Remote Similarity |
NPD7607 |
Clinical (unspecified phase) |
0.6698 |
Remote Similarity |
NPD5601 |
Phase 2 |
0.6698 |
Remote Similarity |
NPD683 |
Approved |
0.6697 |
Remote Similarity |
NPD6824 |
Clinical (unspecified phase) |
0.6696 |
Remote Similarity |
NPD5271 |
Approved |
0.6696 |
Remote Similarity |
NPD5273 |
Approved |
0.6695 |
Remote Similarity |
NPD5867 |
Clinical (unspecified phase) |
0.6684 |
Remote Similarity |
NPD1861 |
Discovery |
0.6684 |
Remote Similarity |
NPD4796 |
Discontinued |
0.6682 |
Remote Similarity |
NPD4897 |
Phase 2 |
0.6682 |
Remote Similarity |
NPD5149 |
Phase 2 |
0.6682 |
Remote Similarity |
NPD7858 |
Clinical (unspecified phase) |
0.6682 |
Remote Similarity |
NPD3783 |
Clinical (unspecified phase) |
0.6682 |
Remote Similarity |
NPD7064 |
Clinical (unspecified phase) |
0.6682 |
Remote Similarity |
NPD5148 |
Clinical (unspecified phase) |
0.6681 |
Remote Similarity |
NPD7797 |
Approved |
0.6681 |
Remote Similarity |
NPD7796 |
Approved |
0.6667 |
Remote Similarity |
NPD4492 |
Approved |
0.6667 |
Remote Similarity |
NPD1743 |
Approved |
0.6667 |
Remote Similarity |
NPD3964 |
Approved |
0.6667 |
Remote Similarity |
NPD7589 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD19 |
Approved |
0.6667 |
Remote Similarity |
NPD4429 |
Discontinued |
0.6667 |
Remote Similarity |
NPD743 |
Approved |
0.6667 |
Remote Similarity |
NPD7546 |
Discontinued |
0.6667 |
Remote Similarity |
NPD6377 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4494 |
Approved |
0.6667 |
Remote Similarity |
NPD5670 |
Approved |
0.6667 |
Remote Similarity |
NPD1742 |
Approved |
0.6652 |
Remote Similarity |
NPD8017 |
Clinical (unspecified phase) |
0.6652 |
Remote Similarity |
NPD8016 |
Phase 3 |
0.6652 |
Remote Similarity |
NPD6223 |
Clinical (unspecified phase) |
0.6651 |
Remote Similarity |
NPD7439 |
Clinical (unspecified phase) |
0.6651 |
Remote Similarity |
NPD3392 |
Approved |
0.6649 |
Remote Similarity |
NPD3248 |
Phase 1 |
0.6649 |
Remote Similarity |
NPD6060 |
Clinical (unspecified phase) |
0.6649 |
Remote Similarity |
NPD6884 |
Clinical (unspecified phase) |
0.6648 |
Remote Similarity |
NPD2791 |
Discontinued |
0.6636 |
Remote Similarity |
NPD7467 |
Discontinued |
0.6636 |
Remote Similarity |
NPD6366 |
Clinical (unspecified phase) |
0.6635 |
Remote Similarity |
NPD7238 |
Clinical (unspecified phase) |
0.6634 |
Remote Similarity |
NPD5994 |
Discontinued |
0.6634 |
Remote Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.6633 |
Remote Similarity |
NPD795 |
Clinical (unspecified phase) |
0.6633 |
Remote Similarity |
NPD1165 |
Clinical (unspecified phase) |
0.6632 |
Remote Similarity |
NPD3789 |
Approved |
0.6632 |
Remote Similarity |
NPD2366 |
Approved |
0.663 |
Remote Similarity |
NPD5481 |
Discontinued |
0.6619 |
Remote Similarity |
NPD6612 |
Phase 2 |
0.6619 |
Remote Similarity |
NPD8164 |
Clinical (unspecified phase) |
0.6616 |
Remote Similarity |
NPD6645 |
Clinical (unspecified phase) |
0.6616 |
Remote Similarity |
NPD1544 |
Phase 1 |
0.6606 |
Remote Similarity |
NPD3437 |
Discontinued |
0.6605 |
Remote Similarity |
NPD3874 |
Discontinued |
0.6602 |
Remote Similarity |
NPD7569 |
Approved |
0.6602 |
Remote Similarity |
NPD7570 |
Approved |
0.6599 |
Remote Similarity |
NPD6894 |
Phase 1 |
0.6599 |
Remote Similarity |
NPD7443 |
Clinical (unspecified phase) |
0.6596 |
Remote Similarity |
NPD1670 |
Discontinued |
0.6592 |
Remote Similarity |
NPD7278 |
Phase 2 |
0.6592 |
Remote Similarity |
NPD7279 |
Phase 2 |
0.659 |
Remote Similarity |
NPD7178 |
Clinical (unspecified phase) |
0.659 |
Remote Similarity |
NPD3888 |
Discontinued |
0.6589 |
Remote Similarity |
NPD7043 |
Discontinued |
0.6588 |
Remote Similarity |
NPD5552 |
Discontinued |
0.6585 |
Remote Similarity |
NPD5114 |
Approved |
0.6585 |
Remote Similarity |
NPD4258 |
Approved |
0.6585 |
Remote Similarity |
NPD4259 |
Approved |
0.6585 |
Remote Similarity |
NPD2410 |
Phase 2 |
0.6585 |
Remote Similarity |
NPD5112 |
Approved |
0.6585 |
Remote Similarity |
NPD5113 |
Approved |
0.6582 |
Remote Similarity |
NPD5847 |
Phase 1 |
0.6581 |
Remote Similarity |
NPD6397 |
Phase 3 |
0.6579 |
Remote Similarity |
NPD6741 |
Clinical (unspecified phase) |
0.6579 |
Remote Similarity |
NPD7072 |
Phase 2 |
0.6578 |
Remote Similarity |
NPD7268 |
Clinical (unspecified phase) |
0.6564 |
Remote Similarity |
NPD2341 |
Discontinued |
0.6562 |
Remote Similarity |
NPD4132 |
Clinical (unspecified phase) |
0.6562 |
Remote Similarity |
NPD6247 |
Clinical (unspecified phase) |
0.6561 |
Remote Similarity |
NPD950 |
Clinical (unspecified phase) |
0.656 |
Remote Similarity |
NPD3945 |
Discontinued |
0.656 |
Remote Similarity |
NPD4455 |
Discontinued |
0.6559 |
Remote Similarity |
NPD1524 |
Phase 1 |
0.6558 |
Remote Similarity |
NPD3472 |
Approved |
0.6558 |
Remote Similarity |
NPD2906 |
Approved |
0.6558
|
Remote Similarity |
NPD2907 |
Approved |